FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\Gadd45UASp.cPa
Open Close
General Information
Symbol
Dmel\Gadd45UASp.cPa
Species
D. melanogaster
Name
FlyBase ID
FBal0219054
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Also Known As
UAS-D-GADD45
Key Links
Transgenic product class
Nature of the Allele
Transgenic product class
Progenitor genotype
Carried in construct
Cytology
Description

UASp regulatory sequences drive expression of the entire Gadd45 coding region.

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Constitutive overexpression of Gadd45Scer\UAS.P\T.cPa under the control of Scer\GAL41407 results in a lifespan increase in both males and females compared to controls. The median lifespan of males with constitutive Gadd45Scer\UAS.P\T.cPa overexpression in the nervous system is extended by 77 and 73% compared to the median lifepsan of males of the parental Gadd45Scer\UAS.P\T.cPa and Scer\GAL41407 strains, respectively. The age of 90% mortality of males with constitutive Gadd45Scer\UAS.P\T.cPa overexpression is increased by 25 and 59% compared to parental Gadd45Scer\UAS.P\T.cPa and Scer\GAL41407 males, and in females by 11 and 50%, respectively. This indicates that constitutive Gadd45Scer\UAS.P\T.cPa overexpression in the nervous system increases lifespan and delays aging in males and females. This effect is larger in males than in females.

Survival curves demonstrate a lifespan increase in males expressing Gadd45Scer\UAS.P\T.cPa in neuronal cells under the control of Scer\GAL4elav.Switch.PO that are treated with mifepristone compared to those kept with mifepristone and males of parental strains. Specifically, the median lifespan of males with mifepristone-inducible Gadd45Scer\UAS.P\T.cPa overexpression in the nervous sytem is higher by 40-42% compared to males with the same genotype not treated with mifepristone, while in females, by 3-6%. The median lifespan of males with conditional Gadd45Scer\UAS.P\T.cPa overexpression in the nervous is increased by 50-70 and 62-84%, compared to the median lifespan of parental Gadd45Scer\UAS.P\T.cPa and Scer\GAL4elav.Switch.PO strain males, respectively, and in females by 27-29 and 100-102%, respectively.

In females with constitutive Gadd45Scer\UAS.P\T.cPa overexpression in the nervous system (under the control of Scer\GAL41407), fecundity is higher over the entire course of lifetime, compared to the parental strain females. The average number of eggs laid daily by a female increases 2-2.3-fold compared to parental strains, while the number of pupae per female is 3.7 and 4.4 times higher, respectively.

In females with Gadd45Scer\UAS.P\T.cPa overexpression in the nervous system (under the control of Scer\GAL4elav.Switch.PO), the average number of eggs laid daily increase 1.7 times compared to the Scer\GAL4elav.Switch.PO parental strain.

The locomotor activity of males and females with constitutive Gadd45Scer\UAS.P\T.cPa overexpression in the nervous system (under the control of Scer\GAL41407) is increased compared with males and females of both parental strains throughout their whole lifetime, both in terms of spontaneous locomotor activity and according to a negative geotaxis test. There is an increase in locomotor activity in males (on day 4-29) and in females (on day 12-36) with conditional expression of Gadd45Scer\UAS.P\T.cPa under the control of Scer\GAL4elav.Switch.PO.

In the neuroblasts of larvae constitutively or conditionally expressing Gadd45Scer\UAS.P\T.cPa in the nervous system under the control of Scer\GAL41407 or Scer\GAL4elav.Switch.PO respectively, the DNA damage level is reduced by 21-27%, with statistical significance compared to control larvae. However, the level of apoptosis seen in these larval neuroblasts does not differ significantly.

Expression of Gadd45Scer\UAS.P\T.cPa under the control of Scer\GAL4CY2 results in apoptosis of the egg chamber, shown by condensation and breaking up of DNA within both the nurse and follicle cells.

Expression of Gadd45Scer\UAS.P\T.cPa under the control of Scer\GAL4GMR.PF does not result in any gross morphological changes in the eye.

Expression of Gadd45Scer\UAS.P\T.cPa under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 results in a broad range of abnormal eggshell phenotypes, ranging from normal morphology to dorsalised. Weakly dorsalised eggs have two broadened dorsal appendages, while moderately dorsalised eggshells have one broadened dorsal appendage on the dorsal midline. A small fraction of the eggs have a more posteriorly located patch of dorsal appendage material.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference

The dorsalised eggshell phenotype caused by expression of Gadd45Scer\UAS.P\T.cPa under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 is significantly suppressed by Df(1)H6, hepG0208/+ or hepr75/+.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (2)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (2)
Reported As
Symbol Synonym
Gadd45Scer\UAS.P\T.cPa
Gadd45UASp.cPa
Name Synonyms
Secondary FlyBase IDs
    References (6)